Skip to content

Clinical trials

Phase 3 Hepatitis B, Chronic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Phase: Phase 3 Country / region: South Korea Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20051
20061
20071
20081
20103
20122
20132
20141
20151
20162
20171
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status5
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Bristol-Myers Squibb3
Gilead Sciences2
GlaxoSmithKline2
IlDong Pharmaceutical Co Ltd2
Novartis2
Chong Kun Dang Pharmaceutical1
Dong-A ST Co., Ltd.1
Hanyang University1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic22
Hepatitis3
Hepatitis B3
Hepatitis, Chronic2
Arthritis, Juvenile1
Arthritis, Psoriatic1
Arthritis, Rheumatoid1
Fibrosis1
Spondylitis, Ankylosing1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.